{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T12:20:01Z","timestamp":1753359601981},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2009,6,30]],"date-time":"2009-06-30T00:00:00Z","timestamp":1246320000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s10585-009-9278-3","type":"journal-article","created":{"date-parts":[[2009,6,29]],"date-time":"2009-06-29T03:00:03Z","timestamp":1246244403000},"page":"789-796","source":"Crossref","is-referenced-by-count":3,"title":["Allelic loss at TP53 in metastatic human endometrial carcinomas"],"prefix":"10.1007","volume":"26","author":[{"given":"Wiktor","family":"Szewczuk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danuta","family":"Skomra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Cybulski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"Prz\u0105dka-Rabaniuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata","family":"Filip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej","family":"J\u00f3\u017awik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Olcha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Roessner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Semczuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,6,30]]},"reference":[{"key":"9278_CR1","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1073\/pnas.76.5.2420","volume":"76","author":"AB Leo De","year":"1979","unstructured":"De Leo AB, Jay G, Appella E, Dubois GC, Law LW, Old LJ (1979) Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse. Proc Natl Acad Sci USA 76:2420\u20132424","journal-title":"Proc Natl Acad Sci USA"},{"key":"9278_CR2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/358015a0","volume":"358","author":"DP Lane","year":"1992","unstructured":"Lane DP (1992) p53, guardian of the genome. Nature 358:15\u201316","journal-title":"Nature"},{"key":"9278_CR3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35042675","volume":"408","author":"B Vogelstein","year":"2000","unstructured":"Vogelstein B, Lane D, Levine AJ (2000) Surfing the p53 network. Nature 408:307\u2013310","journal-title":"Nature"},{"key":"9278_CR4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.bjc.6603886","volume":"97","author":"JC Bourdon","year":"2007","unstructured":"Bourdon JC (2007) p53 and its isoforms in cancer. Br J Cancer 97:277\u2013282","journal-title":"Br J Cancer"},{"key":"9278_CR5","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1054\/bjoc.2001.2128","volume":"85","author":"EE Balint","year":"2001","unstructured":"Balint EE, Vousden KH (2001) Activation and activities of the p53 tumor suppressor protein. Br J Cancer 85:1813\u20131823","journal-title":"Br J Cancer"},{"key":"9278_CR6","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/carcin\/bgh186","volume":"25","author":"D Lane","year":"2004","unstructured":"Lane D (2004) p53 from pathway to therapy. Anthony Dipple Carcinogenesis Award. Carcinogenesis 25:1077\u20131081","journal-title":"Carcinogenesis"},{"key":"9278_CR7","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1038\/sj.onc.1208615","volume":"24","author":"SL Harris","year":"2005","unstructured":"Harris SL, Levine AJ (2005) The p53 pathway: positive and negative feedback loops. Oncogene 24:2899\u20132908","journal-title":"Oncogene"},{"key":"9278_CR8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0300-9084(01)01356-6","volume":"84","author":"DP Guimaraes","year":"2002","unstructured":"Guimaraes DP, Hainaut P (2002) TP53: a key gene in human cancer. Biochimie 84:83\u201393","journal-title":"Biochimie"},{"key":"9278_CR9","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1038\/sj.onc.1210280","volume":"26","author":"T Soussi","year":"2007","unstructured":"Soussi T (2007) p53 alterations in human cancer: more questions than answers. Oncogene 26:2145\u20132156","journal-title":"Oncogene"},{"key":"9278_CR10","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1038\/sj.onc.1210302","volume":"26","author":"A Petitjean","year":"2007","unstructured":"Petitjean A, Achatz MI, Borresen-Dale AL, Hainaut P, Olivier M (2007) TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene 26:2157\u20132165","journal-title":"Oncogene"},{"key":"9278_CR11","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/PGP.0b013e31815daf1a","volume":"27","author":"A Velasco","year":"2008","unstructured":"Velasco A, Pallares J, Santacana M, Yeramian A, Dolcet X, Eritja N, Puente S, Sorolla A, Llecha N, Matias-Guiu X (2008) Loss of heterozygosity in endometrial carcinoma. Int J Gynecol Pathol 27:305\u2013317","journal-title":"Int J Gynecol Pathol"},{"key":"9278_CR12","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00428-002-0695-9","volume":"441","author":"A Semczuk","year":"2002","unstructured":"Semczuk A, Marzec B, Roessner A, Jakowicki JA, Wojcierowski J, Schneider-Stock R (2002) Loss of heterozygosity of the retinoblastoma gene is correlated with the altered pRb expression in human endometrial cancer. Virchows Arch 441:577\u2013583","journal-title":"Virchows Arch"},{"key":"9278_CR13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/106689690401200405","volume":"12","author":"SX Liang","year":"2004","unstructured":"Liang SX, Chambers SK, Cheng L, Zhang S, Zhou Y, Zheng W (2004) Endometrial glandular dysplasia: a putative precursor lesion of uterine papillary serous carcinoma. Part II: molecular features. Int J Surg Pathol 12:319\u2013331","journal-title":"Int J Surg Pathol"},{"key":"9278_CR14","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1245\/s10434-007-9712-1","volume":"15","author":"O Graesslin","year":"2008","unstructured":"Graesslin O, Chantot-Bastaraud S, Lorenzato M, Birembaut P, Quereux C, Darai E (2008) Fluorescence in situ hybridization and immunohistochemical analysis of p53 expression in endometrial cancer: prognostic value and relation to ploidy. Ann Surg Oncol 15:484\u2013492","journal-title":"Ann Surg Oncol"},{"key":"9278_CR15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1159\/000089764","volume":"69","author":"A Semczuk","year":"2005","unstructured":"Semczuk A, Marzec B, Skomra D, Roessner A, Cybulski M, Rechberger T, Schneider-Stock R (2005) Allelic loss at TP53 is not related to p53 protein overexpression in primary human endometrial carcinomas. Oncology 69:317\u2013325","journal-title":"Oncology"},{"key":"9278_CR16","unstructured":"World Health Organisation Classification of Tumours. Pathology and genetics of tumors of the breast and female genital organs (2003) Tavassoli FA, Devilee P (ed.), IACR Press, Lyon"},{"issue":"10 suppl.","key":"9278_CR17","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1002\/1097-0142(19951115)76:10+<2041::AID-CNCR2820761322>3.0.CO;2-Z","volume":"76","author":"JJ Mikuta","year":"1995","unstructured":"Mikuta JJ (1995) Preoperative evaluation and staging of endometrial cancer. Cancer 76(10 suppl.):2041\u20132043","journal-title":"Cancer"},{"key":"9278_CR18","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/clinchem\/39.3.549b","volume":"39","author":"M Hahn","year":"1993","unstructured":"Hahn M, Serth J, Fislage R, Wolfes H, Allhoff E, Jonas V, Pingoud A (1993) Polymerase chain reaction detection of a highly-polymorphic VNTR segment in intron 1 of the human p53 gene. Clin Chem 39:549\u2013550","journal-title":"Clin Chem"},{"key":"9278_CR19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/gcc.2870050113","volume":"5","author":"MH Jones","year":"1992","unstructured":"Jones MH, Nakamura Y (1992) Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism. Genes Chromosomes Cancer 5:89\u201390","journal-title":"Genes Chromosomes Cancer"},{"key":"9278_CR20","first-page":"4963","volume":"18","author":"O Calle-Martin de la","year":"1990","unstructured":"de la Calle-Martin O, Fabregat V, Romero M, Soler J, Vives J, Yague J (1990) AccII polymorphism of the p53 gene. Nucleic Acids Res 18:4963","journal-title":"Nucleic Acids Res"},{"key":"9278_CR21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00004347-200404000-00007","volume":"23","author":"A Alkushi","year":"2004","unstructured":"Alkushi A, Lim P, Coldman A, Huntsman D, Miller D, Gilks CB (2004) Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cut-off level. Int J Gynecol Pathol 23:129\u2013137","journal-title":"Int J Gynecol Pathol"},{"key":"9278_CR22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev.ge.25.120191.001433","volume":"25","author":"D Lasko","year":"1991","unstructured":"Lasko D, Cavenee W, Nordenskjold M (1991) Loss of constitutional heterozygosity in human cancer. Annu Rev Genet 25:281\u2013314","journal-title":"Annu Rev Genet"},{"key":"9278_CR23","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/335400a0","volume":"335","author":"B Ponder","year":"1998","unstructured":"Ponder B (1998) Gene losses in human tumours. Nature 335:400\u2013402","journal-title":"Nature"},{"key":"9278_CR24","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0002-9440(10)65166-8","volume":"155","author":"S Knuutila","year":"1999","unstructured":"Knuutila S, Aalto Y, Autio K, Bjorkqvist AM, El-Rifai W, Hemmer S, Huhta T, Kettunen E, Kiuru-Kuhlefelt S, Larramendy ML, Lushnikova T, Monni O, Pere H, Tapper J, Tarkkanen M, Varis A, Wasenius VM, Wolf M, Zhu Y (1999) DNA copy number losses in human neoplasms. Am J Pathol 155:683\u2013694","journal-title":"Am J Pathol"},{"key":"9278_CR25","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","volume":"68","author":"AG Knudson Jr","year":"1971","unstructured":"Knudson AG Jr (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820\u2013823","journal-title":"Proc Natl Acad Sci USA"},{"key":"9278_CR26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/gcc.2870090207","volume":"9","author":"MH Jones","year":"1994","unstructured":"Jones MH, Koi S, Fujimoto I, Hasumi K, Kato K, Nakamura Y (1994) Allelotype of uterine cancer by analysis of RFLP and microsatellite polymorphisms: frequent loss of heterozygosity on chromosome arms 3p, 9q, 10q, and 17p. Genes Chrom Cancer 9:119\u2013123","journal-title":"Genes Chrom Cancer"},{"key":"9278_CR27","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1093\/jnci\/86.20.1524","volume":"86","author":"X Li","year":"1994","unstructured":"Li X, Lee NK, Ye YW, Waber PG, Schweitzer C, Cheng QC, Nisen PD (1994) Allelic loss at chromosomes 3p, 8p, 13q, and 17p associated with poor prognosis in head and neck cancer. J Natl Cancer Inst 86:1524\u20131529","journal-title":"J Natl Cancer Inst"},{"key":"9278_CR28","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1101\/gad.1339905","volume":"19","author":"J-C Bourdon","year":"2005","unstructured":"Bourdon J-C, Fernandes K, Murray-Zmijewski F, Liu G, Diot A, Xirodimas DP, Saville MK, Lane DP (2005) p53 isoforms can regulate p53 transcriptional activity. Genes Dev 19:2122\u20132137","journal-title":"Genes Dev"},{"key":"9278_CR29","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/S0959-8049(97)00118-4","volume":"33","author":"I Heide","year":"1997","unstructured":"Heide I, Thiede C, Sonntag T, de Kant E, Neubauer A, Jonas S, Peter FJ, Neuhaus P, Herrmann R, Huhn D, Rochlitz CF (1997) The status of p53 in the metastatic progression of colorectal cancer. Eur J Cancer 33:1314\u20131322","journal-title":"Eur J Cancer"},{"key":"9278_CR30","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/00004347-200107000-00002","volume":"20","author":"RN Baergen","year":"2001","unstructured":"Baergen RN, Warren CD, Isacson C, Ellenson LH (2001) Early uterine serous carcinoma: clonal origin of extrauterine disease. Int J Gynecol Pathol 20:214\u2013219","journal-title":"Int J Gynecol Pathol"},{"key":"9278_CR31","first-page":"166","volume":"9","author":"J Kupryjanczyk","year":"1996","unstructured":"Kupryjanczyk J, Thor AD, Beauchamp R, Poremba C, Scully RE, Yandell DW (1996) Ovarian, peritoneal, and endometrial serous carcinoma: clonal origin of multifocal disease. Mod Pathol 9:166\u2013173","journal-title":"Mod Pathol"},{"key":"9278_CR32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/1097-0142(19950701)76:1<72::AID-CNCR2820760110>3.0.CO;2-3","volume":"76","author":"T Kihana","year":"1995","unstructured":"Kihana T, Hamada K, Inoue Y, Yano N, Iketani H, Murao S, Ukita M, Matsuura S (1995) Mutation and allelic loss of the p53 gene in endometrial carcinoma. Incidence and outcome in 92 surgical patients. Cancer 76:72\u201378","journal-title":"Cancer"},{"key":"9278_CR33","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/S0959-8049(98)00270-6","volume":"34","author":"D Niederacher","year":"1998","unstructured":"Niederacher D, An HX, Camrath S, Dominik SI, Gohring UJ, Oertel A, Grass M, Hantschmann P, Lordnejad MR, Beckmann MW (1998) Loss of heterozygosity of BRCA1, TP53 and TCRD markers analysed in sporadic endometrial cancer. Eur J Cancer 34:1770\u20131776","journal-title":"Eur J Cancer"},{"key":"9278_CR34","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/BF01372546","volume":"123","author":"M Saegusa","year":"1997","unstructured":"Saegusa M, Okayasu I (1997) Bcl-2 is closely correlated with favorable prognostic factors and inversely associated with p53 protein accumulation in endometrial carcinomas: immunohistochemical and polymerase chain reaction\/loss of heterozygosity findings. J Cancer Res Clin Oncol 123:429\u2013434","journal-title":"J Cancer Res Clin Oncol"},{"key":"9278_CR35","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1046\/j.1432-1327.2001.02227.x","volume":"268","author":"S-H Liang","year":"2001","unstructured":"Liang S-H, Clarke MF (2001) Regulation of p53 localization. Eur J Biochem 268:2779\u20132783","journal-title":"Eur J Biochem"},{"key":"9278_CR36","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s10585-007-9087-5","volume":"24","author":"R Jeczen","year":"2007","unstructured":"Jeczen R, Skomra D, Cybulski M, Schneider-Stock R, Szewczuk W, Roessner A, Rechberger T, Semczuk A (2007) P53\/MDM2 overexpression in metastatic endometrial cancer: correlation with clinicopathological features and patient outcome. Clin Exp Metastasis 24:503\u2013511","journal-title":"Clin Exp Metastasis"},{"key":"9278_CR37","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1525-1438.2001.01046.x","volume":"11","author":"M Inoue","year":"2001","unstructured":"Inoue M (2001) Current molecular aspects of the carcinogenesis of the uterine endometrium. Int J Gynecol Cancer 11:339\u2013348","journal-title":"Int J Gynecol Cancer"},{"key":"9278_CR38","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1034\/j.1600-0463.2002.1101001.x","volume":"110","author":"HB Salvesen","year":"2002","unstructured":"Salvesen HB, Akslen LA (2002) Molecular pathogenesis and prognostic factors in endometrial carcinoma. APMIS 110:673\u2013689","journal-title":"APMIS"},{"key":"9278_CR39","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.humpath.2004.02.007","volume":"35","author":"J Prat","year":"2004","unstructured":"Prat J (2004) Prognostic parameters of endometrial carcinoma. Hum Pathol 35:649\u2013662","journal-title":"Hum Pathol"},{"key":"9278_CR40","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jsbmb.2007.09.020","volume":"108","author":"A Doll","year":"2008","unstructured":"Doll A, Abal M, Rigau M, Monge M, Gonzalez M, Demajo S, Colas E, Llaurado M, Alazzouzi H, Planaguma J, Lohmann MA, Garcia J, Castellvi S, Ramon y Cajal J, Gil-Moreno A, Xercavins J, Alameda F, Reventos J (2008) Novel molecular profiles of endometrial cancer\u2013new light through old windows. J Steroid Biochem Mol Biol 108:221\u2013229","journal-title":"J Steroid Biochem Mol Biol"}],"container-title":["Clinical &amp; Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-009-9278-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-009-9278-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-009-9278-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T02:57:00Z","timestamp":1589943420000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-009-9278-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,30]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["9278"],"URL":"https:\/\/doi.org\/10.1007\/s10585-009-9278-3","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,30]]}}}